These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25871963)

  • 1. Protein kinase A defects and cortisol-producing adrenal tumors.
    Zilbermint M; Stratakis CA
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
    Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
    N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
    Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
    Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
    Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
    Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
    Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
    Berthon AS; Szarek E; Stratakis CA
    Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.
    Stratakis CA
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3629-33. PubMed ID: 25279575
    [No Abstract]   [Full Text] [Related]  

  • 13. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Causes of Functional Adrenocortical Adenomas.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Endocr Rev; 2017 Dec; 38(6):516-537. PubMed ID: 28973103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
    Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.
    Sargent J
    Nat Rev Endocrinol; 2014 Jun; 10(6):311. PubMed ID: 24751881
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
    Giordano TJ
    Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
    [No Abstract]   [Full Text] [Related]  

  • 18. Rare correlation of somatic PRKACA mutations with pregnancy-associated aldosterone- and cortisol-producing adenomas: a case report and literature review.
    Lin J; Li Y; Huang Z; Zhu Y; Li L; Yang H; Liang X; Qin Y; Zhou J; Xian J; Liu D; Lu D; Luo Z
    BMC Endocr Disord; 2024 Jul; 24(1):116. PubMed ID: 39010034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations.
    Calebiro D; Bathon K; Weigand I
    Horm Metab Res; 2017 Apr; 49(4):307-314. PubMed ID: 27813054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
    Goh G; Scholl UI; Healy JM; Choi M; Prasad ML; Nelson-Williams C; Kunstman JW; Korah R; Suttorp AC; Dietrich D; Haase M; Willenberg HS; Stålberg P; Hellman P; Akerström G; Björklund P; Carling T; Lifton RP
    Nat Genet; 2014 Jun; 46(6):613-7. PubMed ID: 24747643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.